Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: J Heart Lung Transplant. 2011 Dec 14;31(2):140–149. doi: 10.1016/j.healun.2011.11.003

Table 1.

Devices utilized in the RVAD group.

Pulsatile 121 (77.6%)
 Abiomed AB 5000 6 (3.8%)
 Novacor 43 (27.6%)
 HeartMate XVE 33 (21.2%)
 Thoratec IVAD 6 (3.8%)
 Thoratec PVAD 33 (21.2%)
* Continuous Flow 35 (22.4%)
 HeartMate II 15 (9.6%)
 JARVIK 2000 2 (1.3%)
 Ventrassist 18 (11.5%)
Total 156
*

lists the number (percentage) of patients with initial continuous-flow LVAD in RVAD group.